- 2026-12-06
-
QLS5132, a novel claudin 6-targeting antibody-drug conjugate, in patients with platinum- resistant ovarian cancer: Updated results from a phase 1 trial
08:07-08:14
Room 502
Mini Oral
Speaker

Zhuyan Shao
QLS5132, a novel claudin 6-targeting antibody-drug conjugate, in patients with platinum- resistant ovarian cancer: Updated results from a phase 1 trial
08:07-08:14
Room 502
Mini Oral
Speaker